Ailing Zou1,2, Qichao Jian1,2. 1. Department of Dermatology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Health Care Group, Huangshi, Hubei, China. 2. Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, Huangshi, Hubei, China.
Abstract
ABSTRACT: Although several studies have attempted to investigate the etiology of and mechanism underlying psoriasis, the precise molecular mechanism remains unclear. Our study aimed to explore the molecular mechanism underlying psoriasis based on bioinformatics.GSE30999, GSE34248, GSE41662, and GSE50790 datasets were obtained from the Gene Expression Omnibus database. The Gene Expression Omnibus profiles were integrated to obtain differentially expressed genes in R software. Then a series of analyses was performed, such as Gene Ontology annotation, Kyoto Encyclopedia of Genes and Genomes pathway analysis, protein-protein interaction network analysis, among others. The key genes were obtained by CytoHubba, and validated by real-time quantitative polymerase chain reaction.A total of 359 differentially expressed genes were identified between 270 paired lesional and non-lesional skin groups. The common enriched pathways were nucleotide-binding and oligomerization domain-like receptor signaling pathway, and cytokine-cytokine receptor interaction. Seven key genes were identified, including CXCL1, ISG15, CXCL10, STAT1, OASL, IFIT1, and IFIT3. These key genes were validated as upregulated in the 4 datasets and M5-induced HaCaT cells.Our study identified 7 key genes, namely CXCL1, ISG15, CXCL10, STAT1, OASL, IFIT1, and IFIT3, and 2 mostly enriched pathways (nucleotide-binding and oligomerization domain-like receptor signaling pathway, and cytokine-cytokine receptor interaction) involved in psoriatic pathogenesis. More importantly, CXCL1, ISG15, STAT1, OASL, IFIT1, IFIT3, and especially CXCL10 may be potential biomarkers. Therefore, our findings may bring a new perspective to the molecular mechanism underlying psoriasis and suggest potential biomarkers.
ABSTRACT: Although several studies have attempted to investigate the etiology of and mechanism underlying psoriasis, the precise molecular mechanism remains unclear. Our study aimed to explore the molecular mechanism underlying psoriasis based on bioinformatics.GSE30999, GSE34248, GSE41662, and GSE50790 datasets were obtained from the Gene Expression Omnibus database. The Gene Expression Omnibus profiles were integrated to obtain differentially expressed genes in R software. Then a series of analyses was performed, such as Gene Ontology annotation, Kyoto Encyclopedia of Genes and Genomes pathway analysis, protein-protein interaction network analysis, among others. The key genes were obtained by CytoHubba, and validated by real-time quantitative polymerase chain reaction.A total of 359 differentially expressed genes were identified between 270 paired lesional and non-lesional skin groups. The common enriched pathways were nucleotide-binding and oligomerization domain-like receptor signaling pathway, and cytokine-cytokine receptor interaction. Seven key genes were identified, including CXCL1, ISG15, CXCL10, STAT1, OASL, IFIT1, and IFIT3. These key genes were validated as upregulated in the 4 datasets and M5-induced HaCaT cells.Our study identified 7 key genes, namely CXCL1, ISG15, CXCL10, STAT1, OASL, IFIT1, and IFIT3, and 2 mostly enriched pathways (nucleotide-binding and oligomerization domain-like receptor signaling pathway, and cytokine-cytokine receptor interaction) involved in psoriatic pathogenesis. More importantly, CXCL1, ISG15, STAT1, OASL, IFIT1, IFIT3, and especially CXCL10 may be potential biomarkers. Therefore, our findings may bring a new perspective to the molecular mechanism underlying psoriasis and suggest potential biomarkers.
Psoriasis is a chronic and systemic inflammatory cutaneous disorder with a global prevalence of 2% to 3%.[ The occurrence of psoriasis is due to complex interactions among genetics, immunology, and the environment.[ Although many studies have investigated the etiologies and mechanisms, the precise molecular mechanism of psoriasis remains unclear.[ A thorough exploration of psoriasis pathogenesis would be helpful for discovery of potential biomarkers and could provide novel clues for diagnosis and treatment.Bioinformatics has been extensively applied to many diseases, including psoriasis.[ Gene Expression Omnibus (GEO) is an online and free database, that includes various disease gene expression datasets.[ Thus, we can utilize bioinformatics analysis to conveniently explore the molecular mechanism underlying psoriasis from the GEO database.In recent years, many scholars have mined key genes related to the pathogenesis of psoriasis by using bioinformatics methods.[ For example, Gao et al[ reported 7 key genes in psoriasis (HERC6, MX1, OAS2, OASL, OAS3, ISG15, and RSAD2). Meanwhile, Delic et al[ considered AURKA, CSK2, CDC45, CENPE, DLGP5, HMMR, IFIT1, IFI6, IFI27, ISG20, NDC80, NUF2, MCM10, RRM2, SPC25, RSAD2, and TTK as key genes. These conclusions demonstrate that numerous genes are related to the pathogenesis of psoriasis. Thus, we can still explore other key genes from different viewpoints.As we know, the diagnosis of psoriasis is not difficult, however its effective treatment does not exist till now.[ It is helpful to explore key genes for discovering potential biomarkers and provide therapeutic targets for psoriasis. Thus, our primary objective is to search key genes for psoriasis that could be potential biomarkers.In our study, we attempted to identify key genes and associated pathways in psoriasis using bioinformatics analysis, and compare the expression levels of key genes between lesional and non-lesional psoriatic skin based on 4 datasets. Finally, we carried out real-time quantitative polymerase chain reaction (RT-qPCR) experiments in M5 induced HaCaT cells for validation. Since some studies confirmed that M5 (IL-22, TNF-a, IL-17A, IL-1a, and Oncostatin M) can induce a better psoriatic cell model,[ we use it to treat HaCaT cells in our experiments. Therefore, our findings may bring a new perspective to the molecular mechanism underlying psoriasis and suggest potential biomarkers.
Materials and Methods
Microarray datasets collection and identification of differentially expressed genes
Figure 1 demonstrates the workflow of this study. Four microarray datasets (GSE30999,[ GSE34248,[ GSE41662,[ and GSE50790[) were downloaded from GEO (https://www.ncbi.nlm.nih.gov/geo/). A total of 127 paired lesional and non-lesional skin samples were selected as subjects from plaque psoriasis patients in the 4 datasets. All subjects were from homo sapiens and GPL570 platform ([HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array). The detailed sample information was summarized in Table 1 (The data were by the year of March 2021).
Figure 1
The workflow of this study. GO = Gene Ontology, KEGG = Kyoto Encyclopedia of Genes and Genomes, PPI = protein-protein interaction, RT-qPCR = real-time quantitative polymerase chain reaction.
Table 1
Information of 4 datasets.
GEO accession
GSE30999
GSE34248
GSE41662
GSE50790
Organism
Homo sapiens
Homo sapiens
Homo sapiens
Homo sapiens
Tissue
Skin
Skin
Skin
Skin
Platform
GPL570
GPL570
GPL570
GPL570
Sample
Paired LS/NL
Paired LS/NL
Paired LS/NL
Paired LS/NL
Pair no.
85
14
24
4
Type
Plaque psoriasis
Plaque psoriasis
Plaque psoriasis
Plaque psoriasis
Citation
Suárez-Fariñas et al[15]
Bigler et al[16]
Bigler et al[16]
Swindell et al[17]
The workflow of this study. GO = Gene Ontology, KEGG = Kyoto Encyclopedia of Genes and Genomes, PPI = protein-protein interaction, RT-qPCR = real-time quantitative polymerase chain reaction.Information of 4 datasets.The raw data of 4 datasets were collated and analyzed using R software (version4.0.2.). Since the raw data were from 4 different microarray datasets, the collated data were processed by background correction and normalized using the “affy” package,[ and the batch effect was eliminated using the ComBat function of sva package.[ The limma package was used to identify differentially expressed genes (DEGs) between 127 paired lesional and non-lesional psoriatic skin tissues. The cutoff value was set as |logFC| > 1.5 and adjusted P < .05, which was demonstrated as a volcano plot. Then the clustering of samples was shown as a heatmap.
Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses of DEGs
Gene Ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of DEGs were performed using Metascape (http://metascape.org), which is a free and online analysis tool.[ GO annotation comprises cellular component, molecular function, and biological process. The cutoff criteria were a P value < .05, minimum overlap of 3, and minimum enrichment of 1.5.
Protein-protein interaction network construction and screening for key genes
The STRING database (version 11.0, http://www.string-db.org/) was utilized to obtain protein-protein interaction (PPI) information for DEGs (high confidence of 0.7 was chosen).[ Then, Cytoscape 3.8.0 was applied to visualize the PPI network.[ The modules of the PPI network were explored using MCODE, and key genes were screened with CytoHubba. This could provide 12 topological analysis methods to identify the top 10 genes. A key gene was identified, if the gene was predicted to be one of the top 10 genes in all 12 methods. Finally, the interactions between the hub genes were returned to the STRING database for analysis.
Functional enrichment analysis of 7 key genes
To confirm the validity of the 7 key genes, functional enrichment analysis of these genes was further analyzed with http://www.bioinformatics.com.cn.
Validation of 7 key genes in the 4 datasets
The 7 key genes were validated in the 4 aforementioned datasets. Moreover, the relationships between CXCL10 and the other hub genes were also confirmed based on the 4 datasets.
Validation of 7 key genes via RT-qPCR
First, HaCaT cells (Shanghai iCell Bioscience Inc.) were cultured in Dulbecco Modified Eagle's Medium at 37°C in a 5% CO2 environment with 10% fetal bovine serum and 1% penicillin and streptomycin. Then, the cells were treated with 10 ng/mLM5 (IL-22, TNF-a, IL-17A, IL-1a, and Oncostatin M) (PeproTech) for 48 hours to induce the psoriasis cell model.After that, total RNA was extracted from M5-treated HaCaT cells using the TRIpure Total RNA Extraction Reagent (#EP013, ELK Biotechnology, China). Total RNA was reverse transcribed using the EntiLink 1st Strand Cdna Synthesis Kit (#EQ003, ELK Biotechnology, China) according to the manufacturer's protocols. The expression levels of the 7 key genes in HaCaT cells and M5-treated HaCaT cells were detected by RT-qPCR using EnTurbo SYBR Green PCR SuperMix (#EQ001, ELK Biotechnology, China) with the StepOne Real-Time PCR System (Life Technologies). The primer sequences were shown in Table S1, Supplemental Digital Content.
Statistical analysis
The data extracted from GEO datasets were examined by the normality test and homogeneity of variance test. t testing and analysis of variance testing were used for comparisons between 2 groups and among 3 or more groups respectively. Spearman correlation analysis was utilized to investigate the relationships between CXCL10 and other hub genes. GraphPad Prism 8.0.1 was used to perform these tests.
Results
Identification of DEGs
Finally, 359 DEGs were identified between 270 paired lesional and non-lesional skin groups with |logFC| > 1.5 and adjusted P < .05, of which 284 were up-regulated and 65 were down-regulated. The volcano plot and heatmap of DEGs were shown in Figures 2 and 3, respectively.
Figure 2
The volcano plot of differentially expressed genes (DEGs). Red, black, and green dots indicate up-regulated, no significant and down-regulated genes, respectively. A total of 359 DEGs were identified basing on |log2 FC| > 1.5 and adjusted P < .05.
Figure 3
The heatmap of DEGs. The orange and blue colors represent up-regulated and down-regulated genes, respectively. DEGs = differentially expressed genes.
The volcano plot of differentially expressed genes (DEGs). Red, black, and green dots indicate up-regulated, no significant and down-regulated genes, respectively. A total of 359 DEGs were identified basing on |log2 FC| > 1.5 and adjusted P < .05.The heatmap of DEGs. The orange and blue colors represent up-regulated and down-regulated genes, respectively. DEGs = differentially expressed genes.
GO and KEGG pathway analyses of DEGs
The GO annotation of DEGs was mostly enriched in 6 clustering groups, including response to bacterium, defense response to other organism, anti-microbial humoral response, flavonoid glucuronidation, skin development, and monocarboxylic acid metabolic process (Fig. 4A, B). The top 20 GO items were of the biological process group (15), and molecular function group (5) (Table 2). KEGG pathway analysis of DEGs indicated that genes were mostly enriched in 3 clustering groups, including steroid hormone biosynthesis, nucleotide-binding and oligomerization domain (NOD)-like receptor signaling pathway, and cytokine-cytokine receptor interaction (Fig. 4C, D). The top 20 KEGG pathway enriched items were shown in Table 3.
Figure 4
The GO and KEGG pathway analyses of DEGs in Metascape. (A) Heatmap of GO enriched terms colored by P values. (B) Network of GO enriched terms colored by P value. (C) Heatmap of KEGG enriched terms colored by P values. (D) Network of KEGG enriched terms colored by P value. DEGs = differentially expressed genes, GO = Gene Ontology, KEGG = Kyoto Encyclopedia of Genes and Genomes.
Table 2
The top 20 GO items of DEGs.
GO
Category
Description
Count
%
Log10(P)
Log10(q)
GO:0009617
BP
Response to bacterium
53
14.25
−22.54
−18.21
GO:0098542
BP
Defense response to other organism
48
12.9
−22.25
−18.21
GO:0019730
BP
Anti-microbial humoral response
23
6.18
−18.1
−14.22
GO:0052696
BP
Flavonoid glucuronidation
9
2.42
−16.93
−13.18
GO:0043588
BP
Skin development
31
8.33
−13.69
−10.48
GO:0032787
BP
Monocarboxylic acid metabolic process
33
8.87
−9.98
−7.24
GO:0001906
BP
Cell killing
17
4.57
−9.62
−6.91
GO:0032103
BP
Positive regulation of response to external stimulus
20
5.38
−7.45
−5.01
GO:0044282
BP
Small molecule catabolic process
23
6.18
−7.24
−4.82
GO:0009611
BP
Response to wounding
29
7.8
−6.99
−4.58
GO:0008202
BP
Steroid metabolic process
19
5.11
−6.9
−4.51
GO:0016042
BP
Lipid catabolic process
19
5.11
−6.69
−4.3
GO:0006766
BP
Vitamin metabolic process
12
3.23
−6.53
−4.16
GO:0036230
BP
Granulocyte activation
23
6.18
−6.38
−4.02
GO:0002831
BP
Regulation of response to biotic stimulus
12
3.23
−6.17
−3.82
GO:0042379
MF
Chemokine receptor binding
16
4.3
−15.05
−11.66
GO:0016491
MF
Oxidoreductase activity
31
8.33
−7.43
−5
GO:0045236
MF
CXCR chemokine receptor binding
6
1.61
−7.07
−4.65
GO:0004252
MF
Serine-type endopeptidase activity
13
3.49
−6.27
−3.92
GO:0004867
MF
Serine-type endopeptidase inhibitor activity
10
2.69
−6.12
−3.79
Table 3
The top 20 KEGG pathways of DEGs.
GO
Category
Description
Count
%
Log10(P)
Log10(q)
ko00140
KEGG pathway
Steroid hormone biosynthesis
13
3.49
−12.22
−9.75
hsa04621
KEGG pathway
NOD-like receptor signaling pathway
19
5.11
−11.11
−8.9
hsa04060
KEGG pathway
Cytokine-cytokine receptor interaction
24
6.45
−10.74
−8.68
ko05146
KEGG pathway
Amoebiasis
9
2.42
−5.26
−3.91
ko03320
KEGG pathway
PPAR signaling pathway
7
1.88
−4.31
−3.01
hsa05219
KEGG pathway
Bladder cancer
5
1.34
−3.54
−2.29
ko04110
KEGG pathway
Cell cycle
7
1.88
−2.86
−1.65
hsa00630
KEGG pathway
Glyoxylate and dicarboxylate metabolism
4
1.08
−2.84
−1.65
ko04623
KEGG pathway
Cytosolic DNA-sensing pathway
5
1.34
−2.82
−1.64
ko05321
KEGG pathway
Inflammatory bowel disease (IBD)
5
1.34
−2.76
−1.59
ko00100
KEGG pathway
Steroid biosynthesis
3
0.81
−2.65
−1.51
hsa00240
KEGG pathway
Pyrimidine metabolism
6
1.61
−2.47
−1.37
hsa00380
KEGG pathway
Tryptophan metabolism
4
1.08
−2.36
−1.28
hsa04978
KEGG pathway
Mineral absorption
4
1.08
−2.27
−1.2
hsa05150
KEGG pathway
Staphylococcus aureus infection
4
1.08
−1.66
−0.68
hsa05205
KEGG pathway
Proteoglycans in cancer
7
1.88
−1.57
−0.61
hsa00565
KEGG pathway
Ether lipid metabolism
3
0.81
−1.56
−0.61
ko04972
KEGG pathway
Pancreatic secretion
4
1.08
−1.41
−0.48
ko04310
KEGG pathway
Wnt signaling pathway
5
1.34
−1.37
−0.45
ko00561
KEGG pathway
Glycerolipid metabolism
3
0.81
−1.36
−0.44
The GO and KEGG pathway analyses of DEGs in Metascape. (A) Heatmap of GO enriched terms colored by P values. (B) Network of GO enriched terms colored by P value. (C) Heatmap of KEGG enriched terms colored by P values. (D) Network of KEGG enriched terms colored by P value. DEGs = differentially expressed genes, GO = Gene Ontology, KEGG = Kyoto Encyclopedia of Genes and Genomes.The top 20 GO items of DEGs.The top 20 KEGG pathways of DEGs.
PPI network construction and screening for key genes
The PPI network of 359 DEGs was acquired with the STRING database, which was visualized using Cytoscape software (Fig. 5A). Then MCODE was used to identify functional modules. There were 6 modules, of which cluster 1 consisted of 28 nodes and 196 edges (Fig. 5B), including GAL, CXCL13, GBP1, IFIT3, RTP4, IFIT1, MX1, OASL, IFI44, ISG15, CCL27, OAS1, RSAD2, CXCR2, CXCL8, IFI44L, IRF7, STAT1, CXCL1, PTGER3, OAS2, HERC6, IFI6, IFI27, CCL20, CXCL9, CXCL10, and CXCL2 (Table 4). Seven genes, namely CXCL1, ISG15, CXCL10, STAT1, OASL, IFIT1, and IFIT3, were considered the key genes by CytoHubba (Table 5). Subsequently, the relationships among the 7 key genes were explored with the STRING database and CXCL10 was central for the connection (Fig. 5C).
Figure 5
PPI network and hub genes. (A) The PPI network was constructed in Cytoscape, with upregulated genes revealed in red ellipses, downregulated genes in blue ellipses, and cluster 1 genes in yellow ellipses. (B) Cluster 1 network was constructed with upregulated genes revealed in red ellipses and downregulated genes in blue ellipses. (C) The connection function between 7 hub genes in STRING database. PPI = protein-protein interaction.
Table 4
The detailed information of cluster networks in MCODE.
Occurrences in 12 statistical methods by CytoHubba
Full name (human)
1
CXCL1
Up
3.4145
9.27E-42
8
C-X-C motif chemokine ligand 1
1
ISG15
Up
1.9624
2.62E-38
8
ISG15 ubiquitin like modifier
2
CXCL10
Up
2.3289
2.19E-27
7
C-X-C motif chemokine ligand 10
3
STAT1
Up
1.7999
1.36E-47
6
Signal transducer and activator of transcription 1
4
OASL
Up
3.7520
1.47E-66
5
2′-5′-oligoadenylate synthetase like
4
IFIT1
Up
1.7003
3.18E-33
5
Interferon induced protein with tetratricopeptide repeats 1
4
IFIT3
Up
1.6149
4.02E-34
5
Interferon induced protein with tetratricopeptide repeats 3
PPI network and hub genes. (A) The PPI network was constructed in Cytoscape, with upregulated genes revealed in red ellipses, downregulated genes in blue ellipses, and cluster 1 genes in yellow ellipses. (B) Cluster 1 network was constructed with upregulated genes revealed in red ellipses and downregulated genes in blue ellipses. (C) The connection function between 7 hub genes in STRING database. PPI = protein-protein interaction.The detailed information of cluster networks in MCODE.The detailed information of 7 key genes.Seven key genes were further analyzed using an online tool (http://www.bioinformatics.com.cn). The enrichment results of 7 hub genes were shown in chord plots based on the adjusted P values (Fig. 6). For GO analysis, the top 5 terms were response to bacterium, defense response to other organism, anti-microbial humoral response, flavonoid glucuronidation, and chemokine receptor binding (Fig. 6A). For KEGG pathway analysis, the top 3 terms were NOD-like receptor signaling pathway, cytokine-cytokine receptor interaction, and amoebiasis (Fig. 6B). These results were consistent with the Metascape analysis, which strengthened the reliability of the results.
Figure 6
The chord plots of enrichment analysis of 7 hub genes. (A) GO enrichment analysis. (B) KEGG enrichment analysis. GO = Gene Ontology, KEGG = Kyoto Encyclopedia of Genes and Genomes.
The chord plots of enrichment analysis of 7 hub genes. (A) GO enrichment analysis. (B) KEGG enrichment analysis. GO = Gene Ontology, KEGG = Kyoto Encyclopedia of Genes and Genomes.
Validation of 7 key genes in 4 datasets
The expression levels of 7 key genes were confirmed in GSE30999, GSE34248, GSE41662, and GSE50790 datasets. Except for CXCL1, STAT1, and OASL in GSE50790, the other key genes were obviously up-regulated in psoriatic lesional skin tissues (Fig. 7).
Figure 7
The expression of 7 hub genes in 4 datasets. The green bar indicates non-lesional skin groups, and the red bar indicates lesional skin groups. Paired t testing was performed to compare the means of 2 groups. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001; ∗∗∗∗P < .0001. LS = lesional skin, NL = non-lesional skin, ns = no significance.
The expression of 7 hub genes in 4 datasets. The green bar indicates non-lesional skin groups, and the red bar indicates lesional skin groups. Paired t testing was performed to compare the means of 2 groups. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001; ∗∗∗∗P < .0001. LS = lesional skin, NL = non-lesional skin, ns = no significance.
Relationship between CXCL10 and the other key genes
For the relationships among the 7 key genes, CXCL10 was central to the network (Fig. 5C), had a higher rank (Table 5), and a demonstrated positive correlation with the other 6 key genes in the 4 aforementioned datasets (Fig. 8), suggesting the close relationship between CXCL10 and the other 6 key genes.
The expression levels of 7 key genes were validated by RT-qPCR (n = 3). The results of qRT-PCR showed that the transcription levels of CXCL10, CXCL1, ISG15, STAT1, OASL, IFIT1, and ITIT3 were significantly up-regulated in 10 ng/mL M5 induced HaCaT cells (Fig. 9). The expression levels of these genes were consistent with the microarray results.
Figure 9
The results of RT-qPCR. The transcription levels of CXCL10, CXCL1, ISG15, STAT1, OASL, IFIT1, and ITIT3 were significantly up-regulated in M5 group. t testing was performed to compare the means of 2 groups. ∗∗P < .01; ∗∗∗P < .001; ∗∗∗∗P < .0001. M5, HaCat cells were treated with 10 ng/mL M5 (IL-1a, IL-17, IL-22, TNF-α, and Oncostatin M); Control, HaCat cells without M5 stimulation. RT-qPCR = real-time quantitative polymerase chain reaction.
The results of RT-qPCR. The transcription levels of CXCL10, CXCL1, ISG15, STAT1, OASL, IFIT1, and ITIT3 were significantly up-regulated in M5 group. t testing was performed to compare the means of 2 groups. ∗∗P < .01; ∗∗∗P < .001; ∗∗∗∗P < .0001. M5, HaCat cells were treated with 10 ng/mL M5 (IL-1a, IL-17, IL-22, TNF-α, and Oncostatin M); Control, HaCat cells without M5 stimulation. RT-qPCR = real-time quantitative polymerase chain reaction.
Discussion
Psoriasis is a chronic, relapsing-remitting, and inflammatory skin disease that affects 2% to 3% of the population worldwide.[ Recurrence has been common after treatment in psoriasis. That is to say, there are currently no known radical treatments for psoriasis.[ Thus, it is important and urgent to investigate the molecular mechanisms involved in the pathogenesis of psoriasis to provide new clues for treatment. An important discovery of our study was the confirmation of key genes in psoriasis by bioinformatics and via RT-qPCR. The 7 key genes comprised CXCL10, CXCL1, ISG15, STAT1, OASL, IFIT1, and IFIT3, and the 2 common enriched pathways were NOD-like receptor signaling pathway and cytokine-cytokine receptor interaction.Among the 7 key genes, CXCL10 was a higher ranked gene and had positive correlations with other 6 hub genes, suggesting that it might be the most significant gene. Furthermore, the RT-qPCR results of CXCL10 confirmed this prediction. Some studies have also reported several hub genes in psoriasis, some of which are consistent with ours,[ especially the study of Luo et al. They reported that CXCR2, CXCL10, IVL, OASL, and ISG15 were hub genes, and CXCL10 was the hub gene with the highest degree.[ However they did not perform experiments to validate the hub genes. CXCL10 is a member of the CXC family of chemokines, and plays a significant role in inflammation through its T-cell chemotactic and adhesion properties.[ Researches have also indicated CXCL10 is up-regulated in psoriatic skin lesions and serum.[ It has been hypothesized that CXCL10 could be a good marker for psoriasis.[ Although CXCL10 and CXCL1 belong to the chemokine “CXC” family,[ they play different roles in psoriasis. CXCL10 attracts T helper (Th) 1 cells, and whereas CXCL1 attracts neutrophils.[ It was reported that CXCL10 production by keratinocytes depends on STAT1.[STAT1 is known as a member of the STAT family, involved in type I and type II interferon signaling.[ The expression of STAT1 is increased in psoriatic skin, and it also has a vital role in the pathogenesis of psoriasis.[The remaining 4 genes (ISG15, OASL, IFIT1, and IFIT3) are anti-viral genes, which may explain the relatively fewer viral skin infections found in psoriasis patients. Ubiquitin-like protein ISG15 is an interferon-stimulated protein that has a critical role in the control of microbial infections.[ Some studies reported that ISG15 is elevated in psoriatic skin compared with levels in atopic dermatitis skin and healthy skin.[ The interferon-inducible oligoadenylate synthetases-like (OASL) protein belongs to the atypical oligoadenylate synthetase family, possesses anti-viral activity, and boosts innate immunity.[ Gao et al[ also identified OASL as a hub gene, but it has been rarely studied in psoriasis patients. Although the expression of OASL was up-regulated in M5-induced HaCaT cells in our study, this needs to be further confirmed.The IFITs include IFIT1, IFIT2, IFIT3, and IFIT5,[ which regulate immune responses and function as essential anti-viral proteins.[ One study indicated that IFIT3 binding to IFIT1 is vital for stabilizing IFIT1 expression, and is indispensable for inhibiting infection by viruses lacking 2′-O methylation.[ In this study, IFIT1 was enriched in the NOD-like receptor signaling pathway, but IFIT3 was not. Currently, there are few studies on IFITs in psoriasis; however, IFIT1 and IFIT3 are overexpressed in oral squamous cell carcinoma, and promote tumor growth and regional and distant metastasis.[ Therefore, this new finding warrants further study.The NOD-like receptor is a type of pattern-recognition receptor. It is also associated with various diseases related to infection and immunity.[ Some studies showed that the NOD-like receptor signaling pathway was enriched in psoriatic epidermis.[ Meanwhile, some researchers have found that cytokine-cytokine receptor interaction is related to the pathogenesis of psoriasis via combined transcriptomic analysis.[ These results are consistent with ours.In summary, we identified 7 key genes and 2 mostly enriched pathways for psoriasis. Our findings may bring a profound understanding for the molecular mechanism underlying psoriasis. However, this study has some limitations. First, the sample size is limited to a portion of the publicly available datasets and cannot be representative of the entire population. Second, there is potential bias of our data, due to different datasets. Third, we only performed 1 cell experiment. More experiments, such as skin tissues, are needed to support our results.
Conclusion
In our study, we tried to identify DEGs between psoriatic and non-psoriatic lesions by bioinformatics, discovered 7 hub genes and 2 mostly enriched pathways that might participate in the pathogenesis of psoriasis, and validated the hub genes upregulated in a psoriatic cell model through RT-qPCR. More interestingly, the 7 hub genes, namely CXCL1, ISG15, STAT1, OASL, IFIT1, IFIT3, and especially CXCL10 may be used as potential biomarkers. Therefore, our findings may bring a new perspective to the molecular mechanism underlying psoriasis and suggest potential biomarkers.
Acknowledgment
We thank Editage (www.editage.cn) for English language editing of a draft of this manuscript.
Authors: Saumya Choudhary; Dibyabhaba Pradhan; Noor S Khan; Harpreet Singh; George Thomas; Arun K Jain Journal: Curr Pharm Des Date: 2020 Impact factor: 3.116
Authors: Britney Johnson; Laura A VanBlargan; Wei Xu; James P White; Chao Shan; Pei-Yong Shi; Rong Zhang; Jagat Adhikari; Michael L Gross; Daisy W Leung; Michael S Diamond; Gaya K Amarasinghe Journal: Immunity Date: 2018-03-08 Impact factor: 31.745
Authors: A Antonelli; P Fallahi; A Delle Sedie; S M Ferrari; M Maccheroni; S Bombardieri; L Riente; E Ferrannini Journal: Clin Exp Rheumatol Date: 2009 Jan-Feb Impact factor: 4.473
Authors: Damian Szklarczyk; Annika L Gable; David Lyon; Alexander Junge; Stefan Wyder; Jaime Huerta-Cepas; Milan Simonovic; Nadezhda T Doncheva; John H Morris; Peer Bork; Lars J Jensen; Christian von Mering Journal: Nucleic Acids Res Date: 2019-01-08 Impact factor: 16.971
Authors: Mari H Tervaniemi; Shintaro Katayama; Tiina Skoog; H Annika Siitonen; Jyrki Vuola; Kristo Nuutila; Raija Sormunen; Anna Johnsson; Sten Linnarsson; Sari Suomela; Esko Kankuri; Juha Kere; Outi Elomaa Journal: Sci Rep Date: 2016-03-15 Impact factor: 4.379